Opioid agonist treatment in London usually means prescribed methadone or buprenorphine within a continuing care plan. Services also call it opioid substitution treatment, or OST. The purpose can be sustained stability and reduced harm, rather than a short course that must end with detoxification. Access involves an appropriate prescriber, regular review, and reliable arrangements for obtaining the medication.
The World Health Organization’s April 2026 update reaffirmed strong recommendations for maintenance treatment with methadone and oral buprenorphine and added a conditional recommendation for long-acting injectable buprenorphine. That international recommendation supports discussing options; it does not establish the availability of a particular formulation at every London clinic.
Understand what maintenance treatment is trying to achieve
Medication can reduce the repeated cycle of withdrawal, obtaining opioids, and using again. Stability creates room to address other priorities: health, relationships, housing, work, and psychological difficulties. The government’s introduction to OST explains why sustained treatment can be an important part of recovery rather than evidence that recovery has failed.
Physical dependence on a prescribed medicine and an uncontrolled pattern of harmful use are not identical concepts. A patient may function more consistently while receiving supervised, reviewed treatment. Language such as “just replacing one addiction with another” can obscure the actual questions: is the medicine helping, are risks being managed, and is the person’s life becoming more stable?
The treatment plan should identify those goals in concrete terms. For one person, an early priority is avoiding daily withdrawal and overdose risk. Another may already be stable and want help returning to education. A medication review should make room for those different situations rather than using the same endpoint for everyone.
For the broader condition and assessment process, read opioid use disorder treatment in London. If the immediate question is how to manage withdrawal, our separate opioid withdrawal care guide addresses that discussion without assuming withdrawal is the right next step for every patient.
Methadone and buprenorphine are different choices
NICE guidance on oral methadone and buprenorphine recommends both as treatment options, with the choice informed by the person’s needs, preferences, benefits, and risks. They should be provided with supportive care. Previous experience matters, but a friend’s successful prescription cannot determine another person’s medicine or dose.
Methadone is a full opioid agonist; buprenorphine acts as a partial agonist. Their pharmacology, interaction risks, and starting arrangements differ. Neither is safe to borrow or begin without assessment. Tell the prescriber about recent opioid use, periods without opioids, other sedatives, alcohol, breathing problems, and previous difficulties when starting or switching medication.
The Department of Health and Social Care’s updated recommendations say treatment systems should make both options available and explain when one is unsuitable. They also support rapid prescribing for appropriate patients, including at first attendance. That is a clinical access standard, not a promise that anyone requesting a particular drug will receive it immediately.
A useful comparison asks what each option would mean during the first week, after stabilization, and when ordinary life changes. Discuss collection frequency, existing medicines, previous treatment response, and the prescriber’s reasons for their recommendation. If an explanation rests only on what the service usually does, ask how your circumstances were considered.
When a long-acting injection may enter the discussion
Long-acting buprenorphine offers another way of receiving treatment. Change Grow Live’s information about Buvidal describes a preparation administered under the skin by a healthcare professional, with weekly or monthly schedules. It can remain part of ongoing maintenance treatment; an injection does not mean that the need for clinical review disappears.
This option may appeal to someone who finds frequent pharmacy collections difficult or does not want medication stored at home. Others may prefer an oral formulation or have clinical reasons for a different choice. Ask how starting, switching, follow-up appointments, and missed injection appointments are handled at the actual service considering your treatment.
Confirm local availability before rearranging work or transferring care. A national provider’s general information page is not evidence that every one of its borough services offers the same appointment pathway. Likewise, a formulary listing does not guarantee immediate access, an accepted referral, or suitability for an individual patient.
How to start the conversation in London
The NHS explains that help can start with a GP or direct contact with a local drug treatment service. Give your home borough and explain whether you are already prescribed medication elsewhere. Someone seeking a transfer needs a different administrative response from someone having a first assessment.
As one local example, Tower Hamlets RESET explicitly lists access to opioid substitute treatment and regular medical reviews with a prescriber. Its community service includes keyworker support and other health interventions. Eligibility and the arrangements offered should be checked with that service; its listing does not make it a London-wide walk-in prescribing clinic.
When making contact, explain any immediate supply problem plainly: the medicine, usual prescriber, pharmacy, last collection, and reason continuity is at risk. Do not disguise a missed-dose problem as a new request for general counseling. Staff need the relevant information to arrange clinical advice rather than place you in an unrelated appointment queue.
Make pharmacy arrangements fit the real week
The NHS methadone guidance explains that the prescriber and pharmacy need to coordinate supply. Early treatment often involves supervised consumption. Tell the service if commuting, disability, caring responsibilities, or work hours make the proposed arrangement difficult. A collection schedule that cannot be followed needs discussion before it repeatedly breaks down.
Current English guidance makes supervision an individualized assessment, including the medication, safety, and risk of treatment becoming inaccessible. It should not be assumed that every patient must follow the same fixed period of supervision. Ask when the arrangement will be reviewed and what information will guide that review.
Write down the agreed pharmacy, collection days, and contact route for a problem. Include weekends and public holidays. If you work near Liverpool Street but live in another borough, for example, clarify the practical location with the treatment team rather than assuming any nearby pharmacy can dispense an existing prescription.
Privacy also matters. The government’s community pharmacy guidance emphasizes dignity, confidentiality, and communication with treatment services. Ask how a private conversation can be arranged if discussing medication at the public counter feels difficult. Reporting a concern about the process need not mean abandoning care.
Missed doses need advice, not an improvised restart
Tell the pharmacy or prescriber promptly if doses have been missed. The NHS advises against taking extra methadone to compensate, and a pharmacy may need to consult the prescriber before supplying medication after an interruption. Do not assume that a previously tolerated dose remains appropriate after a gap or obtain someone else’s supply.
Ask in advance what the service wants you to do when illness, transport disruption, or a lost phone prevents attendance. Keep a usable contact number somewhere besides the phone. An emergency plan is more helpful when it names a route that operates during the hours you are likely to need it.
If someone becomes unconscious or struggles to breathe after taking opioids, call 999. The NHS advises giving naloxone if available and following the call handler’s advice. Medication reviews and collection problems are important, but they should not delay emergency help for suspected overdose.
Hospital admissions and borough moves require a handover
Guy’s and St Thomas’ patient information describes assessment by hospital staff and addiction or liaison specialists, including a plan for continuing treatment in the community after discharge. Tell admitting staff about OST early, including the service and pharmacy that can verify the current prescription and recent supply.
Before discharge, ask who has contacted the community team and which pharmacy will provide the next dose. A discharge letter saying “continue usual medication” may leave practical questions unresolved. The aim is a confirmed transition, with accurate medication information and no confusion about whether hospital and community supplies overlap.
For a planned move across London, raise the transfer while still engaged with the existing service. Record the receiving team, acceptance status, first appointment, and who prescribes until responsibility changes. National pharmacy guidance calls for careful verification of supply dates and prescriptions when care transfers; patients should not have to infer these details from separate letters.
Keep wider care connected to medication
At review, describe function as well as substance use: whether you can sleep, attend appointments, care for children, or stay alert at work. An unexplained change deserves discussion even when collections have been regular. A completed prescription record cannot show the whole experience of treatment.
Ongoing treatment can also involve mental health care, infection testing, social support, and help with safer relationships and housing. Choose the next priorities with the team. If depression or another condition is being treated elsewhere, coordinated dual diagnosis care explains how shared planning can reduce contradictory instructions between services.
Ask for access to naloxone and an explanation suitable for anyone likely to be present in an emergency. Keep prescribed medication secure and never share it. If future reduction is a personal goal, discuss it openly with the prescriber as a planned clinical decision. Continuing effective treatment while strengthening daily life is a valid outcome in its own right.